Methylmalonyl-CoA mutase deficiency: Difference between revisions
CSV import |
No edit summary |
||
| Line 8: | Line 8: | ||
Methylmalonyl-CoA mutase is an enzyme that catalyzes the conversion of methylmalonyl-CoA to succinyl-CoA, a critical step in the degradation of certain amino acids, such as [[valine]], [[isoleucine]], [[methionine]], and [[threonine]]. This reaction is part of the [[citric acid cycle]], which is essential for energy production in cells. | Methylmalonyl-CoA mutase is an enzyme that catalyzes the conversion of methylmalonyl-CoA to succinyl-CoA, a critical step in the degradation of certain amino acids, such as [[valine]], [[isoleucine]], [[methionine]], and [[threonine]]. This reaction is part of the [[citric acid cycle]], which is essential for energy production in cells. | ||
In individuals with methylmalonyl-CoA mutase deficiency, the enzyme is either absent or not functioning properly, leading to the accumulation of methylmalonic acid and other toxic substances in the body. This accumulation can cause a variety of symptoms and complications, including metabolic acidosis, developmental delay, and organ damage. | In individuals with methylmalonyl-CoA mutase deficiency, the enzyme is either absent or not functioning properly, leading to the accumulation of methylmalonic acid and other toxic substances in the body. This accumulation can cause a variety of symptoms and complications, including metabolic acidosis, developmental delay, and organ damage. | ||
| Line 31: | Line 29: | ||
== Treatment == | == Treatment == | ||
Treatment for methylmalonyl-CoA mutase deficiency often involves dietary management to limit the intake of certain amino acids that cannot be properly metabolized. In some cases, vitamin B12 (cobalamin) supplementation may be beneficial, particularly in patients with a cobalamin-responsive form of the disorder. | Treatment for methylmalonyl-CoA mutase deficiency often involves dietary management to limit the intake of certain amino acids that cannot be properly metabolized. In some cases, vitamin B12 (cobalamin) supplementation may be beneficial, particularly in patients with a cobalamin-responsive form of the disorder. | ||
Revision as of 15:04, 22 February 2025
Methylmalonyl-CoA Mutase Deficiency
Methylmalonyl-CoA mutase deficiency is a rare metabolic disorder that affects the body's ability to break down certain proteins and fats. It is a type of organic acidemia and is caused by a deficiency in the enzyme methylmalonyl-CoA mutase (MUT), which is crucial for the metabolism of certain amino acids and lipids.
Pathophysiology
Methylmalonyl-CoA mutase is an enzyme that catalyzes the conversion of methylmalonyl-CoA to succinyl-CoA, a critical step in the degradation of certain amino acids, such as valine, isoleucine, methionine, and threonine. This reaction is part of the citric acid cycle, which is essential for energy production in cells.
In individuals with methylmalonyl-CoA mutase deficiency, the enzyme is either absent or not functioning properly, leading to the accumulation of methylmalonic acid and other toxic substances in the body. This accumulation can cause a variety of symptoms and complications, including metabolic acidosis, developmental delay, and organ damage.
Clinical Presentation
The clinical presentation of methylmalonyl-CoA mutase deficiency can vary widely among affected individuals. Symptoms may appear in the neonatal period or later in life, depending on the severity of the enzyme deficiency.
Common symptoms include:
- Poor feeding
- Vomiting
- Lethargy
- Hypotonia
- Developmental delay
- Failure to thrive
- Metabolic acidosis
Diagnosis
Diagnosis of methylmalonyl-CoA mutase deficiency is typically made through a combination of clinical evaluation, biochemical testing, and genetic analysis. Elevated levels of methylmalonic acid in the blood and urine are indicative of the disorder.
Treatment
Treatment for methylmalonyl-CoA mutase deficiency often involves dietary management to limit the intake of certain amino acids that cannot be properly metabolized. In some cases, vitamin B12 (cobalamin) supplementation may be beneficial, particularly in patients with a cobalamin-responsive form of the disorder.
Complications
If left untreated, methylmalonyl-CoA mutase deficiency can lead to serious complications, including:
- Neurological damage
- Chronic kidney disease
- Pancreatitis
- Cardiomyopathy
Related Pages
See Also
| Metabolic disorders | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
This metabolic disorder related article is a stub.
|
